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Abstract
Chaperone networks are required for the shearing and generation of transmissible propagons from pre‐existing
prion aggregates. However, other cellular networks needed for maintaining yeast prions are largely
uncharacterized. Here, we establish a novel role for actin networks in prion maintenance. The [PIN +] prion, also
known as [RNQ +], exists as stable variants dependent upon the chaperone machinery for the transmission of
propagons to daughter cells during cell division and cytoplasmic transfer. Loss of the Hsp104 molecular
chaperone leads to the growth of prion particles until they are too large to be transmitted. Here, we isolated a
unique [PIN +] variant, which is unstable in actin mutants. This prion loss is observed over many generations, and
coincides with the detection of both high molecular weight species of Rnq1 and large visible aggregates that are
asymmetrically retained during cell division. Our data suggest that the irregular actin networks found in these
mutants may influence propagon number by slowly permitting aggregate growth over time, resulting in the
generation of nontransmissible large aggregates. Thus, we show the potential contribution of cytoskeletal
networks in the transmission of prion propagons, which parallels models that have been proposed for cell‐to‐cell
transmission of small amyloids in neurodegenerative protein aggregation diseases.
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This study establishes a novel role for actin networks in prion maintenance. A unique variant of the [PIN +] prion
is unstable in actin mutants carrying mutations within a binding site for Fimbrin, a conserved actin bundling
protein. Our data suggest that irregular actin networks can influence propagon number by slowly permitting
aggregate growth over time, resulting in the generation of non‐transmissible propagons.

1. INTRODUCTION

Several neurodegenerative and systemic disorders such as prion disease, Huntington's disease, and
Transthyretin amyloidosis are considered protein misfolding disorders. In each of these disorders, one specific
protein population can misfold and assemble into large inclusions that are considered hallmarks of these

diseases. In many cases, the misfolded protein is associated with different types of protein aggregates. There are
small oligomeric complexes and high molecular weight species that are commonly observed as fibrils or
inclusions. The small oligomeric complexes tend to be toxic, possibly due to their ability to diffuse freely
(Lambert et al., 1998; Glabe, 2006; Winner et al., 2011), whereas large fibrils or high molecular weight
aggregates possibly sequester smaller toxic oligomers dampening toxicity (Arrasate et al., 2004).
While a single disease is associated with the misfolding and aggregation of a specific protein, a range of
symptoms and disease on‐set are observed in patients (reviewed in Igel‐Egalon et al., 2018). The difference in
disease presentation is associated with different physical protein conformations, commonly referred to as
strains in mammalian systems. In the case of prion disease, different protein conformations among strains
exhibit distinct glycosylation patterns, protease resistance, and protein sedimentation profiles (Bessen and
Marsh, 1992; Collinge et al., 1996; Parchi et al., 1996; Khalili‐Shirazi et al., 2005). These differences account for
the differences in clinical symptoms and incubation times among prion disease patients, and in relative abilities
to jump species barriers.
Recently the link between aggregate size and strain conformation has become clearer. Work by Morales and
coworkers (2016) has found that a certain prion strain associated with longer incubation times also had
extremely large aggregates as shown by sedimentation studies. This correlation suggests the proportion of
protein associated with large molecular weight species could play an important role in phenotypes associated
with specific strains. Therefore, it can be envisioned that shifting protein populations from the oligomeric state
to large aggregates can lead to less detrimental phenotypes. However, the cellular mechanisms involved in
maintaining these different protein populations are poorly understood.
The study of prions in yeast has greatly contributed to our understanding of protein aggregate populations and
prion strains. In yeast, several proteins have been shown to form amyloids called prions (Cox, 1965;
Lacroute, 1971; Wickner, 1994; Derkatch et al., 1997; Sondheimer and Lindquist, 2000; Volkov et al., 2002; Du et
al., 2008; Alberti et al., 2009; Patel et al., 2009; Rogoza et al., 2010; Halfmann et al., 2012; Suzuki et al., 2012).
Similar to human amyloids, these yeast proteins can misfold, and form both small oligomers and high molecular
weight aggregates. The transmission of most yeast prions to daughters is dependent upon chaperone networks.
Hsp104, along with Hsp70 and Hsp40 chaperones, works to shear larger aggregates into smaller transmissible
seeds or propagons (Shorter and Lindquist, 2004, 2008; Aron et al., 2007; Higurashi et al., 2008; Winkler et
al., 2012).
Yeast prions can also adopt alternative protein conformations with distinct biochemical characteristics and
phenotypes (Wickner, 1994; Glover et al., 1997; King et al., 1997; Sondheimer and Lindquist, 2000;
Schlumpberger et al., 2001; Bradley et al., 2002; Bradley and Liebman, 2003). However, due to nomenclature
conventions within the yeast field, prion strains are often referred to as variants in yeast. Two yeast prions,
[PSI +] and [PIN +], have contributed most substantively to advancing our understanding of prion variants. [PSI +]
is the misfolded aggregating form of the Sup35 protein, and the [PIN +] prion (also referred to as the [RNQ+]
prion) is the misfolded aggregating form of the Rnq1 protein. In the case of [PIN +], distinct variants have a range
of visual fluorescent aggregate phenotypes (Bradley and Liebman, 2003; Huang et al., 2013), and differential
abilities to promote the formation of the [PSI +] prion (Derkatch et al., 1997; Derkatch et al., 2001; Osherovich
and Weissman, 2001; Bradley et al., 2002). It has been shown that during the prion formation process, a single
cell can harbor more than one conformation subtype. The transmission of specific subtypes to daughter cells
leads to the propagation of certain variants, some of which are more stable than others (Sharma and
Liebman, 2012; Huang et al., 2013). While the cellular mechanisms that lead to the destabilization of specific
subtypes are not well defined, some mechanisms have been uncovered via treatment with external stresses. For
example, transient heat shock leads to loss of the weak [PSI +] variant from cell populations (Bailleul et al., 1999;
Wegrzyn et al., 2001; Klaips et al., 2014) as a result of asymmetrical retention of Hsp104 (Klaips et al., 2014).

Despite our understanding of how molecular chaperones influence prion stability, other cellular mechanisms
involved in prion propagation are poorly understood.
In this study, we exploited a unique variant of the [PIN +] prion to show that actin cytoskeletal networks
influence prion stability. This prion variant, while stable in different wildtype genetic backgrounds, is lost over
many generations in actin point mutants, which have irregular actin networks. This instability over time
correlates with the observation of large transient fluorescent foci and the detection of higher molecular weight
aggregates over time. Taken together, results suggest that normal actin cytoskeletal networks play an important
role in maintaining a population of small propagons that are transmissible. Our study uncovers a role for the
actin cytoskeletal network in the maintenance of prion transmission over many generations.

2. RESULTS
2.1. High [PIN +] is mitotically stable, routinely cytoduced with high fidelity, but has
aggregation profiles influenced by genetic background

In order to understand what influences the stability of [PIN +], we needed to establish a baseline of the
frequency of prion loss and transmission fidelity. We confirmed that several variants of [PIN +], including high
[PIN +], were maintained over several hundred generations (Figure S1). Next, we used a process called
cytoduction, which transfers cytoplasmic, but not nuclear, material from a donor to a recipient cell (see
Experimental Procedures; Conde and Fink, 1976). The donor strain was wildtype C10B‐H49 high [PIN +]
(represented by cell a, Figure 1a), and the recipient strain was wildtype BY4741 [pin −]. Throughout the
remainder of this manuscript, C10B‐H49 and BY4741 will be used to refer to the wildtype genotype of their
respective strain backgrounds, whereas any variation from this genotype will be indicated by the strain
background preceded by a mutant allele designation (Table S1). Analysis of cell populations containing high
[PIN +] in the C10B‐H49 genetic background showed that the majority of cells contain multiple Rnq1‐GFP
fluorescent foci that are highly mobile. This phenotype is commonly called multiple‐dot (m.d.) [PIN +]
(Figure 1a,b; cell a; Figure S2; Bradley and Liebman, 2003). It should be noted that terms such as “high” versus
“m.d.” both refer to the identical [PIN +] variant, and the different names reflect the historical characterization
of [PIN +] variants by their relative ability to promote formation of the [PSI +] prion (such as low or high [PIN+];
Bradley et al., 2002) versus their visual fluorescent aggregate phenotypes (such as single or multiple dots;
Bradley and Liebman, 2003).

FIGURE 1 The aggregation phenotype of high [PIN +] in the C10B‐H49 background is maintained after it is
transferred through the BY4741 genetic background. (a) Diagram of cytoduction, with representative fluorescent
micrographs below. All cytoductions involved transfer of prions from a [PIN +] donor to a [pin −] recipient.
Diagram and fluorescent images depict the prion variant after cytoduction. A high [PIN +] C10B‐H49 donor
(represented by cell a) was used to introduce the prion into a [pin −] BY4741 background. The resulting
cytoductant is represented by cell b. Cell b (high [PIN +] BY4741) was used to introduce the prion into a [pin −]
version of C10B‐H49. The cytoductant is represented by cell c. Transient overexpression of Rnq1‐GFP allows for
the detection of aggregates within the cytoductants. Representative images are deconvolved maximum image
projections of several z‐stacks. (b) Cells containing multiple dots (m.d.), single dot (s.d.), or petite foci (p.f.) were
assessed in four independent cultures from each strain. A minimum of 300 cells per culture was scored and
means of each population are shown. The number of m.d.‐containing cells in BY4741 recipient strains were
significantly different compared to C10B‐H49 donor and recipient cells, as determined by Chi‐square test of
independence (p < .0001). (c) Fresh lysates from the indicated strains, including C10B‐H49 [pin −] in the first lane,
were run on an SDD‐AGE and analyzed by Western blot using anti‐Rnq1 antibody. Due to several cross‐reacting
bands between 20 and 120 kDa using this polyclonal antibody, SDD‐AGE is able to confirm presence or absence
of higher molecular weight oligomers, but does not have adequate resolution to affirm presence of the Rnq1
monomer. More definitive evidence for the presence of Rnq1 monomer in [pin −] strains is provided via SDS‐
PAGE (Figure S5). (d) Lysates from the indicated strains, including 74D‐694 [pin −] as the top row, were loaded
onto discontinuous sucrose (10%, 40%, and 60% sucrose) gradients and fractionated. 10 fractions were

collected. Fractions 7 and 8 usually are the interphase between the 40% and 60% sucrose. Protein pelleted at
the bottom of the gradient (P) and whole‐cell lysates (L) are shown [Colour figure can be viewed
at wileyonlinelibrary.com]
Upon introducing high [PIN +] from the C10B‐H49 donor strain into a BY4741 [pin −] recipient by cytoduction, we
observed changes in Rnq1‐GFP aggregate phenotype. Within the BY4741‐cytoduced population, 65.8% of the
cells exhibited a single static fluorescent focus, commonly called single dot (s.d.) [PIN +] (represented by cell b,
Figure 1a,b; Figure S3). Analysis of replicate cultures confirmed these differences in fluorescent aggregate
phenotypes. Bradley and Liebman (2003) reported that a similar cytoduction maintained a multiple‐dot
phenotype. However, authors did not appear to quantify the number of cells within a population that had
multiple dots versus any other aggregate phenotype. We found quantifications of populations extremely
important, designating the population phenotype as m.d. or s.d. [PIN +] according to that which was present in
the majority (>50%) of cells. It was also observed that a small subset of cells in both backgrounds exhibited
previously described petite foci (p.f.), which are very small foci detectable at 630× magnification (Huang et
al., 2013). The systematic characterization of cell populations within a culture, with respect to these aggregate
phenotypes, provided a general “aggregate profile” for each genetic background (Figure 1b).
To confirm that this altered aggregation profile did not represent a permanent change of the prion, we
cytoduced the prion from BY4741 back into a [pin −] version of C10B‐H49. The C10B‐H49 cytoductants had an
aggregation profile comparable to the original C10B‐H49 donor strain (represented by cells c and a, respectively,
Figure 1a,b). In fact, comparison of time‐lapse movies of the predominant cell type in these three strains
showed that both C10B‐H49 cells a and c had similar highly mobile m.d. aggregates, unlike the predominant cell
type in BY4741 cell b with static s.d. aggregates (Figures S2–S4). These data suggest that while the aggregation
profile is different in the BY4741 background, the profile reverted back to the m.d. aggregation phenotype.
Presence of the [PIN +] prion was further validated biochemically, by the absence of an Rnq1 band in unboiled
lysates (Figure S5), and by the detection of similarly sized SDS‐resistant oligomers and large molecular weight
species (Figure 1c,d). [PIN +] was also detected functionally by the ability to promote [PSI +] formation
(Figure S6). Taken together, these data are consistent with prior observations demonstrating that the process of
cytoduction does not typically alter prion variants (Bateman and Wickner, 2013). Thus, throughout the
remainder of this manuscript, we will refer to the [PIN +] variant in the BY4741 and C10B‐H49 genetic
backgrounds (represented by cells a‐c) as high [PIN +], but refer to these visual differences as the s.d. and m.d.
aggregate profiles or phenotypes.

2.2. A unique [PIN +] variant: µdot [PIN +]

We serendipitously isolated a unique [PIN +] variant in a separate study looking at factors influencing prion
formation. We previously found that decreased [PSI +] formation was observed in several single gene knockout
strains that influenced actin organization, including deletion of the Fimbrin actin bundling
homolog SAC6 (Manogaran et al., 2011). As part of this study, we cytoduced high [PIN +] into four [pin −]
recipient temperature‐sensitive actin mutants that had been constructed in the BY4741 genetic background,
including act1‐120, which contains mutations within the Sac6‐binding region of actin (Figure S7a; Holtzman et
al., 1994; Honts et al., 1994; Amberg et al., 1995; Miao et al., 2016). All actin mutants showed severe growth
defects at restrictive temperature, limited growth defects at permissive temperature, and larger cell size
distribution at permissive temperatures (Figure S7b,c; Wertman et al., 1992). While only two of the
mutants, act1‐122 and act1‐120, exhibited either depolarized or partially polarized actin patches within a
majority of cells (Figure S7d), all four actin mutants had comparable Rnq1‐GFP aggregate profiles associated
with library [PIN +], a [PIN +] variant endogenously found in BY4741 strains (Figure S7e; Manogaran et al., 2010).

When high [PIN +] from C10B‐H49 strains was cytoduced into [pin −] recipient actin mutants, the act1‐120, act1‐
101, and act1‐129 mutants all displayed the s.d. aggregate profile (Figure 2a, represented by
cell d, act1 mutant), similar to wildtype BY4741 (cell b). In contrast, act1‐122 BY4741 mutants exhibited an
entirely different aggregation phenotype (Figure 2a, cell d; act1‐122). At first glance, the cells appeared to have
diffuse cytoplasmic fluorescence (Figure 2b). However, upon closer inspection, the cells contained many small
mobile foci, visible by time‐lapse microscopy (Figure S8). The small foci are considerably smaller than the petite
foci (p.f.) previously observed by Huang et al. (2013). In this paper, we will call this new aggregation pattern of
Rnq1‐GFP “micro dot” (µ.d.).

FIGURE 2 New aggregation phenotype, µ.d., found in act‐122 cytoductant. (a) High [PIN +] was cytoduced from
wildtype C10B‐H49 (cell a) into [pin −] BY4741 wildtype or actin mutant recipient strains. The diagram depicts the
prion variant after cytoduction. The type of aggregates found in each strain was counted as described in
Figure 1b. Each bar represents the mean of four independent cultures and a minimum of 300 cells per culture.
(b) Fluorescent micrographs of [PIN +] in wildtype BY4741 and act1‐122 BY4741 strains. While representative
images are deconvolved maximum image projections of several z‐stacks, additional contrast was added to
cell d to demonstrate the visual differences between both strains (see Figure S8 for raw time‐lapse images)
[Colour figure can be viewed at wileyonlinelibrary.com]
We expected that if [PIN +] were cytoduced from act1‐122 BY4741 back into a wildtype C10B‐H49 [pin −]
recipient strain, the visual aggregates would revert back to the m.d. aggregation profile of high [PIN +] in that
background, similar to our previous observations in Figure 1. However, the C10B‐H49 cytoductants retained the
µ.d. aggregation phenotype (represented by cell e, Figure 3a,b). Similar to the µ.d. aggregates in the act1‐
122 BY4741 mutants, initial inspection suggested that C10B‐H49 cells exhibited diffuse fluorescence
(Figure 3a,b, cell e), but time‐lapse microscopy showed that these cells also contained many small mobile foci
(Figure S9). Additionally, population analysis reveals that the µ.d. aggregate phenotype is present in a relatively
comparable proportion of cells in act1‐122 BY4741 and these C10B‐H49 strains (represented by cells d and e;
Figure 3c). The [PIN +] status of these strains was verified by the presence of SDS‐resistant oligomers (Figure 3d).

FIGURE 3 Microdot phenotype does not revert to multiple dots when introduced into the C10B‐H49 background.
(a) µdot [PIN +] in the act1‐122 strain (cell d) was cytoduced into the C10B‐H49 background (cell e). (b)
Fluorescent images of cells a, d, and e. (c) Similar to Figures 1b and and2c,2c, each bar represents the mean of at
least four independent cultures and a minimum of 300 cells per culture. (d) Western blot of lysates of the
indicated strains, including wildtype BY4741 [pin −] in the first lane, run on SDD‐AGE gels. Anti‐Rnq1 antibody
was used to detect Rnq1 oligomers [Colour figure can be viewed at wileyonlinelibrary.com]
[PIN +] status was also verified functionally by the ability of all strains to promote [PSI +] formation (Figure S6c).
Notably, induction frequencies of strains within the same C10B‐H49 genetic background, but with m.d. (cell c;
S6C) versus µ.d. (cell e) aggregation phenotypes, are significantly different. Moreover, the ability to retain the
µ.d. aggregation profile between the act1‐122 BY4741 and the wildtype C10B‐H49 strains (cells d to e) is in stark
contrast to the cytoduction of high [PIN +] from the wildtype BY4741 genetic background into a C10B‐H49 [pin −]
recipient strain (Figure 1a,b, cell b to cell c), where reversion from the s.d. to m.d. aggregation profile was
observed (Figure 1b). It should also be noted that DNA sequencing showed that RNQ1 gene sequences were
identical between strains, eliminating any concerns that the different aggregation profiles were due
to RNQ1 polymorphisms (data not shown). Collectively, these data demonstrate that the µ.d. aggregation
phenotype is associated with a prion variant that is unique from high [PIN +], and to distinguish the prion variant
from the aggregation phenotype, we refer to the variant as µdot [PIN +].
We considered the possibility that the act1‐122 mutation would reproducibly change high [PIN +] into µdot
[PIN +]. Therefore, we replicated the original cytoduction experiment, transferring high [PIN +] from C10B‐H49
into act1‐122 BY4741 [pin −] recipient strains (e.g., repeating cell a to cell d cytoductions). Analysis of several
independent cytoductions showed that act1‐122 BY4741 strains can acquire aggregation profiles that were

phenotypically indistinguishable from wildtype BY4741 cytoduced with high [PIN +] (Figure S10). Therefore, our
data suggest that the µdot [PIN +] variant arose due to a rare event coincident with cytoduction.

2.3. Fluorescent aggregates of µdot [PIN +] exhibit transient larger aggregates

Our initial observations and aggregate profile determinations of µdot [PIN +] revealed presence of a very small
subpopulation of cells with intensely bright foci similar to single‐ or multiple‐dot foci in both act1‐122 BY4741
and in C10B‐H49 (Figure 3c, s.d. and m.d. categories for cells d and e), although such cells were slightly less
frequent in C10B‐H49 (Figure 3c, cell e). Using 3D time‐lapse microscopy, we followed individual cells of this type
from both strains, and observed rapid dispersal of these bright foci to a µ.d. aggregate phenotype (Figure 4a).
Prolonged time‐lapse microscopy was performed on multiple cells from four independent cultures of act1‐
122 BY4741 µdot [PIN +] strains. These time‐lapse videos show that the larger aggregates coalesce and disperse
several times (Figure 4b). The duration in which large aggregates were detected was highly variable, yet the
duration often increased with each successive appearance. In addition, passage of these large aggregates to the
daughter cells was never observed in any of the four time‐lapse analyses (data not shown).

FIGURE 4 Cells containing µdot [PIN+] show transient large aggregates. (a) 3D time‐lapse imaging of cell d (act1‐
122) or cell e (wildtype C10B‐H49) containing µdot [PIN+]. The appearance and disappearance of large
aggregates are indicated with arrowheads. (b) A 3D time‐lapse of a single dividing cell shows the appearance
and disappearance of large aggregates over several cell divisions. All 3D time‐lapse imaging was done without
addition of copper sulfate, such that low Rnq1‐GFP fluorescence reflects trace amounts of copper sulfate in the
synthetic complete media (see Experimental Procedures) [Colour figure can be viewed
at wileyonlinelibrary.com]

2.4. Actin mutants can render µdot [PIN +] unstable

The cytoduction of high [PIN +] from BY4741 (cell b) into a C10B‐H49 [pin −] recipient strain (cell c) faithfully
transmitted the prion (100%, Table 1), whereas our initial efforts to cytoduce µdot [PIN +] from the act1‐
122 BY4741 mutant (cell d) into a C10B‐H49 [pin −] recipient strain (cell e) were variable (3.85%–100%,Table 1).
Some C10B‐H49 cytoductants faithfully received µdot [PIN +] and other cytoductants were [pin −]. Interestingly,
we were able to transmit µdot [PIN +] faithfully through a variation of the cytoduction technique called

plasmiduction (see Experimental Procedures; Natsoulis et al., 1994; Vitrenko et al., 2007), where cytoplasmic
transfer is monitored through the transfer of a plasmid. We used a plasmid containing RNQ1‐GFP driven by a
copper‐inducible promoter to facilitate immediate screening for [PIN +] cytoductants, but copper was not added
during the cytoduction procedure. We found that all C10B‐H49 cytoductants possessing the plasmid also
contained µdot [PIN +] (Table 1). We suspect that a low level of Rnq1‐GFP gene expression by the copper‐
inducible promoter, resulting from low levels of copper found intrinsically in the synthetic media (see
Experimental Procedures), may have contributed to maintenance of µdot [PIN +] through plasmiduction.
TABLE 1 Cytoduction of μdot [PIN +] into C10B‐H49 cells was variable
Cytoductions
Donor

Recipient

Percent cytoductants that
retained [PIN +]
100% (16/16)

cell b
cell c
BY4741 high [PIN +]
C10B‐H49
cell d
cell e
95.6% (22/23)
BY4741 μdot [PIN +] −
C10B‐H49
cell d
cell e
100% (23/23)
BY4741 μdot [PIN +]
C10B‐H49
cell d
cell e
3.85% (1/26)
BY4741 μdot [PIN +]
C10B‐H49
cell d
cell e
95.6% (22/23)
+
BY4741 μdot [PIN ]
C10B‐H49
Plasmiductions
cell b
cell c
100% (32/32)
BY4741 high [PIN +] +
C10B‐H49
RNQ1‐GFP
cell d
cell e
100% (8/8)
BY4741 μdot [PIN +] +
C10B‐H49
RNQ1‐GFP
cell d
cell e
100% (8/8)
BY4741 μdot [PIN +] +
C10B‐H49
RNQ1‐GFP
cell d
cell e
100% (8/8)
+
BY4741 μdot [PIN ] +
C10B‐H49
RNQ1‐GFP
cell d
cell e
100% (8/8)
BY4741 μdot [PIN +] +
C10B‐H49
RNQ1‐GFP
No<del author="Anita L Manogaran" command="Delete" timestamp="1590519650903" title="Deleted by Anita
L Manogaran on 5/26/2020, 2:00:50 PM" class="reU3">te</del>
Cytoduction or plasmiduction were used to introduce µdot [PIN +] into [pin −] recipients with the C10B‐H49
genetic background. One wildtype control (M362, high [PIN +] cell b) and four act1‐122 strains (M363‐M365,
M378; µdot [PIN +] cell d) were used as prion donors [pin −] C10B‐H49 recipient cells to generate cells c and e,
respectively (see Experimental Procedures). Individual cytoductants were mated to tester strains
containing RNQ1‐GFP plasmids and scored for the presence of aggregates in cytoductant cell populations. The
percentage of [PIN +] cytoductants is shown with total number of cytoductants screened in parentheses. Since
plasmiductants already contained the RNQ1‐GFP plasmid, plasmiductants were directly scored for the presence

of Rnq1‐GFP aggregates in cell populations. Each line represents a single mating between donor and recipient
cells.
Based on the variability of µdot [PIN +] transfer through cytoduction, we postulated that µdot [PIN +] in act1‐
122 BY4741 strains may be unstable. Therefore, we performed mitotic stability experiments in the absence of
the plasmid containing RNQ1‐GFP. The act1‐122 BY4741 µdot [PIN+] strain was subcloned from frozen glycerol
stocks on rich media and grown up to 100 generations. Wildtype BY4741 strains containing high [PIN+] were
tested in parallel as a control. To check for the presence of [PIN +] after 100 generations, single colonies were
picked and mated with a [pin −] tester containing the copper‐inducible RNQ1‐GFP plasmid. Rnq1‐GFP was
transiently induced in individual diploid colonies, and each colony was individually scored for the presence of
Rnq1‐GFP aggregates within the cell population. We found that all wildtype BY4741 high [PIN +] colonies (cell b)
contained [PIN +], even after 100 generations (Figure 5a,b). However, act1‐122 BY4741 µdot [PIN +]‐containing
strains (cell d) showed a dramatic decrease in the number of colonies that were [PIN +] by generation 40.
Moreover, prion loss seemed to continue as the cells underwent further division (Figure 5b).

FIGURE 5 µdot [PIN+] is mitotically unstable in BY4741 strains containing the act1‐122 and act1‐120 mutations.
(a) µdot [PIN+] from cell e was cytoduced into wildtype BY4741 (cell f), act1‐122 BY4741 (cell g), or act1‐
120 BY4741 (cell h). Cytoductions involving cells a through e are described on the previous figures. (b) Strains
represented by cells b and d were propagated for the indicated generations. Individual colonies were mated to a
Rnq1‐GFP tester strain and each diploid colony was scored for the complete loss of [PIN +] by the detection of
diffuse fluorescence in all of the cells within the population. The number of colonies scored (n) is indicated
above each data point. In generations 60–100, the act1‐122 BY4741 strain (cell d) lost the [PIN +] prion in a linear
manner (R 2 = 1), whereas loss was not observed in wild type (slope = 0; R 2 = 1). The slope of [PIN +] loss in act1‐
122 BY4741 is significantly different from wild type (p < 0.005). (c) The percent of colonies that lost the prion in
C10B‐H49 strains containing either high [PIN +] (cell c) or µdot [PIN+] (cell e) after 100 generations of growth. (d)
Percent of colonies that lost µdot [PIN+] in wildtype (cell f), act1‐122 (cell g), or act1‐120 (cell h) strains. (e)
Comparison of prion loss for all BY4741 strains. All strains were propagated for 100 generations, both with and
without the RNQ1‐GFP plasmid (p3034), and individual colonies were scored for [PIN+] loss. (f) A summary of
prion loss of all strains (cells b through h). Colonies composed only of cells containing diffuse fluorescence
([pin −], white box), colonies composed of a mix of cells with either diffuse or fluorescent aggregates (partial,
gray box), and colonies where all cells have aggregates ([PIN +]; black box) are shown. (g and h) Prion loss
observed in individual trials (replicates using independent lab strains, Table S1) of act1‐122 BY4741 (cell d or g)
and act1‐120 BY4741 (cell h) strains containing µdot [PIN+]. For all charts, values provided above individual bars
or graph data points indicate the total number of colonies assayed.
Given the instability of µdot [PIN +] in act1‐122 BY4741, we asked whether the same µdot [PIN +] variant would
also be unstable once we had cytoduced the prion back into [pin −] recipient with the C10B‐H49 genetic
background. Using µdot [PIN +] C10B‐H49 cytoductants (cell e) obtained via plasmiduction, plasmids were lost
from the cytoductants by subcloning strains on nonselective rich media, and then strains were successively
subcloned on rich media for an additional 100 generations. µdot [PIN +] appeared to be faithfully maintained
throughout these 100 generations, similar to high [PIN +] in the same wildtype genetic background (cells c and e,
Figure 5c).
Given the stability of µdot [PIN +] observed in the C10B‐H49 genetic background one could draw two possible
conclusions: (1) prion stability is dependent upon genetic context (i.e., presence of the act1‐122 mutation,
BY4741 genetic background, or both), or (2) that this subsequent cytoduction (from cell d to cell e) had imposed
a selection for stable prion conformers. To differentiate between these possibilities, we completed one
additional set of cytoductions back into [pin −] recipients of wildtype BY4741 and act1‐122 BY4741 (Figure 5a;
from cell e to cells f and g). We also decided to include a related yet independent actin [pin −] recipient mutant
strain, act1‐120 BY4741 (cell h), which contains two point mutations within the Sac6‐binding region of actin
(E99A/E100A). Based upon our observations in Table 1, these cytoductions were completed in the presence of
the copper‐inducible RNQ1‐GFP plasmid (without supplemented copper) to enhance successful transmission of
µdot [PIN +] to the recipient cell, and facilitate immediate confirmation of [PIN +] status. RNQ1‐GFP plasmids
were lost from the cytoductants, as described above, and cytoductants were successively subcloned on rich
media through 100 generations. Similar to C10B‐H49 (cell e), all of the wildtype BY4741 colonies (cell f) had
faithfully maintained µdot [PIN +] throughout the 100 generations, whereas both act1‐122 and act1‐120 BY4741
with µdot [PIN +] were subject to prion loss (cells g and h; Figure 5d). These data support the concept that
integrity of the actin network plays an important role in propagating [PIN +]. It is important to note that other
[PIN +] variants such as high [PIN +] and library [PIN +] are stably maintained in these actin mutants (Figure S11),
indicating that this unique prion variant is able to uncover the role of actin in prion stability.
Since the presence of the copper‐inducible RNQ1‐GFP plasmid provided faithful transmission of µdot [PIN +]
through plasmiduction (Table 1), we postulated that the presence of the same plasmid may stabilize the prion
in act1‐122 and act1‐120 BY4741 µdot [PIN +] strains through mitosis. We found that the simple presence of

the RNQ1‐GFP plasmid, without any additional copper supplementation, enabled µdot [PIN +] to be faithfully
maintained for 100 generations (Figure 5e). Similar to the cytoduction experiments (Table 1), the ability to
rescue µdot [PIN +] instability with addition of even modest levels of Rnq1‐GFP suggests that the level of
endogenous Rnq1 protein alone is not sufficient to maintain µdot [PIN +] through mitosis in BY4741 act1‐
122 or act1‐120 mutants.
In addition to noting the impact of Rnq1‐GFP on maintenance of µdot [PIN +] in these act1 mutant alleles, we
were interested in learning more about the progression of [PIN+] loss. Closer inspection of the visual aggregate
profiles among the 100 generation act1‐122 and act1‐120 strains relative to wildtype genetic backgrounds
showed that some colonies were completely comprised of diffuse cell populations, indicating that all the cells in
the colony were [pin −], whereas other colonies displayed a mixed population of cells with some containing
aggregates and others exhibiting diffuse fluorescence (partial, Figure 5f). It seems likely that those colonies that
have a portion of cells with aggregates are in the process of losing the prion from the population.
Several independent act1‐122 and act1‐120 strains were checked for µdot [PIN +] stability spanning 100
generations. Some strains exhibited very little prion loss, whereas others showed more accelerated prion loss
(Figure 5g,h). The variability in loss among strains suggests that the rate of prion loss, and possibly what triggers
loss, is influenced by varied biological or environmental factors within independent derived lineages. Taken
together, our data suggest that BY4741 strains with act1‐122 or act1‐120 mutations can render µdot [PIN +]
unstable.

2.5. Prion aggregates become larger over time in act1‐122 mutants

Based on work with Hsp104, prion loss can occur through growth of the aggregate, leading to poor transmission.
Therefore, we were interested in whether µdot [PIN +] loss in act1‐122 BY4741 was due to an increase in Rnq1
aggregate size. In act1‐122 BY4741 µdot [PIN +] strains grown for 60 generations, Rnq1 was found to fractionate
to the pellet, indicative of extremely large molecular weight complexes (cell d, Figure 6). Fractionation of Rnq1
to the pellet was not observed in either wildtype C10B‐H49 or BY4741 strains containing high [PIN +] (Figure 1d),
or wildtype C10B‐H49 strains containing µdot [PIN +] grown for 60 generations (cell e; Figure 6a). To further
confirm that Rnq1 aggregates become larger over time in act1‐122 BY4741 mutants with µdot [PIN +], we looked
at Rnq1 fractionation profiles at 20 and 60 generations in the act1‐122 BY4741 that had been newly cytoduced
with µdot [PIN +] (cell g, Figure 6c). Rnq1 was not readily detectable in pellet fractions at 20 generations, but was
clearly evident by 60 generations, consistent with Rnq1 aggregates growing in size over time.

FIGURE 6 µdot [PIN+] aggregates increase in size over time in act1‐122 mutants. (a) Cell lysates from cells a, d,
and e were fractionated on a discontinuous (10%, 40%, 60%) sucrose gradient. Cells d and e were the same
strains shown in Figure 5c,d that were grown for 60 generations. As in Figure 1, fraction 1 represents the top of
the gradient, fraction 10 is the bottom. The lane labeled P shows protein found in the pellet of gradient and L is
whole‐cell lysates. (b) Cell g was propagated for either 20 or 60 generations and lysates were run on
discontinuous sucrose gradients. Each gel image is representative of biological replicate trials.

3. DISCUSSION
In this study, we obtained a variant of [PIN +] coincident with cytoduction that had different phenotypic
properties from the original high [PIN+] variant. While able to be transmitted through cytoduction, this new µdot
[PIN +] variant was lost over many generations in both act1‐122 and act1‐120 BY4741 mutant backgrounds
(Figure 5). This loss was correlated with the presence of large visual Rnq1‐GFP foci (Figure 4) as well as the
production of extremely large molecular weight species (Figure 6). Discovery of this new variant has provided
valuable insight into the role of actin networks in prion propagation, specifically the ability of the actin
cytoskeleton to influence the availability of transmissible aggregates for prolonged propagation of prions over
many generations.

3.1. µdot [PIN +]: unknown origin and stochastic loss

The mechanism by which we obtained the µdot [PIN +] variant is unclear. Most known prion variants are
reproducibly propagated and cytoduced as the same conformer. Cells containing newly formed prion aggregates
can yield progeny with multiple variants, but once transmitted over several generations, only one variant is
detectable (Bradley et al., 2002; Sharma and Liebman, 2012). Therefore, the detection of an alternate prion
variant through cytoduction is unexpected. Two models have been proposed whereby new prion variants may
be obtained (Bateman and Wickner, 2013). Either a cloud of different variants is simultaneously propagated and
sometimes certain variants dominate through cytoduction (Bateman and Wickner, 2013) or conversion occurs
through a rare mistemplating event where a new prion variant forms from a pre‐existing prion (Roberts et
al., 2009; Lin et al., 2011).

The observed rate of µdot [PIN +] loss from individual act1‐122 or act1‐120 BY4741 cell lineages was variable
(Figure 5). Even though loss appears to be stochastic among cell lineages, the variability could reflect
unidentified factors such as aging or environmental stimuli, differences in rate of loss per generation, or perhaps
a difference in timing of some triggering event that initiates prion loss. Coincident with the concept of stochastic
loss over many generations, we see that Rnq1 is associated with high molecular weight species only after about
60 generations in BY4741 act1‐122 µdot [PIN +] strains (Figure 6). Other studies have observed that higher
molecular weight species are associated with some de novo generated [PIN +] variants that were quickly lost
after only a few generations (Huang et al., 2013). Therefore, the gradual accumulation of higher molecular
weight species over many generations, which seems to specifically occur in the presence of irregular cytoskeletal
networks, may also contribute substantially to the stochastic nature of µdot [PIN +] loss in these strains.

3.2. Propagons, actin, and prion stability

It is also possible that with the increased size of Rnq1 aggregates, a smaller number of propagons are available
to be transmitted to daughter cells. It has been shown that different [PIN +] variants have different propagon
numbers (Sharma and Liebman, 2013). For example, high [PIN +] has four times more propagons as low [PIN +]. It
is possible that µdot [PIN +] naturally has a low propagon number. However in the presence of compromised
actin networks, the growth of the prion aggregate leaves less Rnq1 protein available for the propagon
generation. This idea of an insufficient amount of protein available for the generation of propagons is supported
by the fact that when additional Rnq1‐GFP is introduced, µdot [PIN +] is stable in act1‐122 and act1‐120 BY4741
mutant backgrounds even after 100 generations (Figure 5).
It is interesting that loss of µdot [PIN +] is observed in actin mutants but not wildtype cells, suggesting that actin
could have a direct role in the transmission of propagons to daughter cells. Several studies have shown a link
between actin and prion formation (Ganusova et al., 2006; Manogaran et al., 2011; Speldewinde et al., 2017).
For example, loss of the actin bundling protein, Sac6, leads to reduced prion formation (Manogaran et al., 2011).
However, this study is the first to show that actin networks can influence the stability of a prion, albeit a certain
variant. Since both act1‐122 and act1‐120 mutants contain substitutions within the Sac6 actin‐binding region
(Holtzman et al., 1994; Honts et al., 1994; Amberg et al., 1995; Miao et al., 2016), and these mutants display
actin patch depolarization (Figure S7), it is possible that actin bundling or actin patch polarization is required for
prion stability. It has also been suggested that the actin/myosin network plays a role in depositing excess prion
aggregates into amyloid deposition sites near the vacuole (Kumar et al., 2016), but how transport of prion
aggregates to these inclusion sites contributes to prion stability is unclear. However, there may be other
explanations that imply that actin has an indirect role. Given that actin mutant cells have increased average cell
size relative to wildtype cells (Figure S7), we also considered the potential role cell size may play in rendering
µdot [PIN +] unstable. However, cell size alone is insufficient to cause prion loss because both library and high
[PIN +] are maintained in these strains (Figure S11). Because both act1 mutants exhibiting µdot [PIN +] instability
are in the same BY4741 genetic background, determining whether something in the BY4741 background
contributes to instability will require further investigation. While our data cannot rule out the influence of cell
size, or other contributing factors, these studies seem to suggest a “perfect storm” scenario where the
combination of irregular actin networks, accumulation of higher molecular weight aggregates, possible lower
propagon number, and cell size compound to render the µdot [PIN +] variant unstable.
We also considered whether µdot [PIN +] loss in these actin mutants may be mediated through Hsp104. A link
between Hsp104 and actin networks has been suggested in the retention of heat shocked or oxidatively
damaged proteins, using actin networks to move and asymmetrically sequester those proteins in the mother cell
(Erjavec and Nystrom, 2007; Tessarz et al., 2009; Liu et al., 2011; Song et al., 2014). A similar mechanism of actin
network‐mediated asymmetric retention appears to work on aggregates of the heterologous human HTT103Q
amyloid (Liu et al., 2011; Song et al., 2014). Under this model of interaction, irregular actin networks would be

expected to reduce asymmetric retention in the mother, and thereby enhance prion transmission to daughter
cells, rather than reduce prion transmission as observed here. Additionally, if these actin mutations were
interfering with Hsp104 activity, we would expect destabilization of all [PIN +] variants, but we observed that
other [PIN +] variants are maintained normally in these strains (Figure S11). However, it has been shown that a
size threshold for the transmission of propagons through the budneck exists for the [PSI +] prion (Derdowski et
al., 2010). It is possible that the observed increase in µdot [PIN +] aggregate size over many generations
(Figure 6) results in prion loss because these large prion propagons are above the size threshold to pass through
the bud neck.
These findings parallel models involving cytoskeletal networks that have been proposed for the cell‐to‐cell
transmission of small amyloids to other neurons in neurodegenerative protein aggregation diseases. In one
model, oligomers and fibrils are proposed to be packaged into exosomes to be released from the cell, and taken
up by nearby neurons through actin‐mediated endocytosis (Fevrier et al., 2004; Miranda and Di Paolo, 2018).
Another model involving cytoskeletal networks involves tunneling nanotubules, which are normally used to
transfer organelles between neurons, but which may also serve as a conduit for transfer of amyloid oligomers or
aggregates (Gousset et al., 2009; Victoria and Zurzolo, 2017). It is possible that dysfunction of cytoskeletal
networks could limit the transmission or spreading of amyloid in vivo. Regardless of what other factors may
contribute to µdot [PIN +] instability, our data provide support that cytoskeletal networks play a role in prion
propagation and thereby stability.

4. EXPERIMENTAL PROCEDURES
4.1. Strains and plasmids

Yeast strains in 74D‐694, BY4741, or C10B‐H49 genetic backgrounds were used as indicated (Table S1). BY4741
strains of act1‐120, act1‐122, act1‐101, and act1‐129 were originally made by Wertman et al. (1992), and more
recently validated and tagged with NATR selection by the Amberg lab (Viggiano et al., 2010). All act1 mutants
were sequenced to confirm the strains contained mutations in the ACT1 gene. Upon transformation with
plasmids containing RNQ1‐GFP (p3034 or p3036), these strains were found to contain the “library” variant of
[PIN +] (as described by Manogaran et al., 2010). These BY4741 strains were cured of all prions by subcloning at
least three times on 5 mM Guanidine–HCl (GuHCl), and verified for the loss of prions by transiently
expressing Sup35PrD‐GFP (p3031) or RNQ1‐GFP (p3034 or p3036) fusion proteins and visualizing diffuse
fluorescence indicative of the nonprion state. Strains and plasmids used in this study are listed in
Tables S1 and S2.

4.2. Cultivation procedures

Yeast strains were grown using standard media and cultivation procedures (Sherman et al., 1986). Complex
media containing 2% dextrose (YPD) or synthetic complete media containing the required amino acids and 2%
dextrose (SD) was used as indicated. A major component of the synthetic complete media is yeast nitrogen base
(BD Difco), which contains trace amounts of copper sulfate, resulting in final concentrations up to 0.25 µM.
Strains transformed with plasmids were maintained on synthetic complete media lacking the specific amino
acid.

4.3. Fluorescent microscopy

To detect the Rnq1 protein by fluorescent microscopy, strains were transformed with a plasmid containing a
copper‐inducible pCUP1‐RNQ1‐GFP (p3034, HIS3). For 3D microscopy, cells were grown for 16–18 hours in
plasmid selective media. To induce plasmid expression, 10–50 µM of copper sulfate was added to the media and
cultures were grown for an additional 4–6 hours. Cultures were screened for the presence of GFP aggregates
using either a 63× (oil immersion, N.A. 1.4) or 100× (oil immersion, N.A. 1.44) objective. µdot [PIN +] was most

easily detected with the 100× objective. Z‐stack images containing between 10‐ and 21‐step z‐stacks were
captured under a DMI6000 Leica inverted microscope using Leica LASX software. To ensure captured images
were able to resolve the aggregate details for print, images were subjected to 3D deconvolution using
Autoquant deconvolution algorithms with background removed and intensity rescaled (Media Cybernetics). All
images shown are maximum projection unless indicated otherwise. For counting cells with aggregates, a
minimum of 300 cells were counted in at least three independent cultures.
Time‐lapse microscopy of cultures was performed according to Sharma et al., (2017). Briefly, cells were grown
for 6 hours in synthetic media without added copper, but containing trace concentrations up to 0.25 µM
(Cultivation procedures). While this concentration is approximately 1/40–1/200 the concentration routinely
added to induce plasmid expression, it proves sufficient to yield detectable Rnq1‐GFP fluorescence. 50 μL of
culture was added to 250 μL of fresh selective media, and placed in concanavalin A‐coated Ibidi 1 µ‐slide 8‐well
glass bottom slides. 3D images were captured every 10 minutes over 6–12 hours. To adjust for low Rnq1‐GFP
fluorescence levels, videos were subjected to deconvolution and maximum projection as indicated above to
resolve aggregate dynamics.

4.4. Cytoduction and plasmiduction of prions

Cytoduction is the transfer of cytoplasm from one cell to another, and can be used to transfer prions from a
donor strain to a [pin −] recipient strain. The presence of a kar1 mutation permits mating and mixture of cellular
contents, but prevents fusion between the nuclei of donor and recipient strain (Conde and Fink, 1976).
Cytoduction can be monitored by mitochondrial transfer, but a variation of cytoduction, sometimes referred to
as plasmiduction, can be monitored by transfer of plasmid‐born markers from a donor strain to a [pin −]
recipient strain (Natsoulis et al., 1994). It has been reported that better cytoplasmic [PIN +] transfer can be
achieved using plasmid‐based markers (Vitrenko et al., 2007).
All recipient strains were streaked on 5mM guanidine hydrochloride three times to cure the prion. To verify
prion loss, all strains were transformed with copper‐inducible RNQ1‐GFP plasmid (p3034 or p3036), or mated to
tester strains containing the RNQ1‐GFP plasmid, and viewed under fluorescent microscopy for diffuse
cytoplasmic fluorescence after 4 hours of 50 µM copper induction. Comparable fluorescence assays were
completed using Sup35PrD‐GFP (p3031) to confirm that all strains were [psi −].
Cytoduction was performed to transfer prions from some BY4741 strains to a C10B‐H49 recipient strain
(Figures 1a,3a, and Table 1; D101), which was [pin −] [psi −] [rho0] and contained a cycloheximide recessive allele.
After mating, cytoductants were selected on YPGlycerol media supplemented with cycloheximide. Cytoductants
were verified for growth on selective media, and saved to glycerol stocks. The transfer of prions from cell b to c,
or cell d to e, was also repeated through plasmiduction, and all transfer of prions to cells f, g, and h were
performed through plasmiduction using the RNQ1‐GFP (HIS3, p3034) plasmid. The presence of [PIN +] among
resulting plasmiductants was verified by the presence of fluorescent aggregates (as described above). Confirmed
[PIN +] plasmiductants were saved as glycerol stocks (Table S1), simultaneously streaked on rich media to lose
the plasmid containing RNQ1‐GFP, and then resaved as glycerol stocks with no plasmid (Table S1).

4.5. Biochemical analysis

Cell lysates were prepared from 50 ml of overnight cultures and lysed according to Sharma et al. (2017). 100 µg
of crude lysates was treated with 2% SDS‐Buffer and boiled (for SDS‐PAGE) or unboiled (for SDD‐AGE). For
sucrose gradient analysis, 8 mg of freshly prepared protein lysate was loaded on a discontinuous sucrose
gradient (10%, 40%, and 60% sucrose in lysis buffer). The discontinuous gradient allows for the capture of large
Rnq1 aggregates between the 40% and 60% interface, which was typically in the 7th or 8th fraction (Figure 1d).
Gradients were spun at 16,000× g for approximately 130 minutes. 10 fractions were immediately removed from

the gradient, and the pellet was resuspended in 1X lysis buffer with protease inhibitor. All fractions were diluted
in half and loaded on SDS‐PAGE. All gels were transferred onto PVDF and immunoblotted with anti‐Rnq1
polyclonal antibody (courtesy of Dr. Heather True, Washington University).

4.6. Mitotic stability

All original BY4741 plasmiductants were selected using a HIS3 plasmid that also contains RNQ1‐GFP to facilitate
immediate scoring for [PIN +]. The RNQ1‐GFP‐containing plasmid (HIS3, p3034) was lost by subcloning cultures
on YPD, and selecting individual colonies that grew on synthetic complete media (SD12) but failed to grow on
SD‐His media. These strains were immediately saved to glycerol stocks (See Table S1). [PIN +] stability
experiments were initiated upon streaking each strain on YPD fresh from glycerol stocks, pooling at least 20
comparably sized colonies, and streaking this pool on YPD to yield ~100 single colonies representing 40
generations from cryogenic storage. These “40‐generation” single colonies were picked directly into 96‐well
plates, including blinded [PIN +] and [pin −] controls, pinned to YPD plates for overnight growth, and mated with
D163 tester strain transformed with a plasmid that contains RNQ1‐GFP (LEU2, p3036). Diploids were selected on
SD‐Leu‐Ura plates, and pinned to deep well plates containing 750 µl of SD‐Leu‐Ura liquid with 25 µM CuSO4 for
overnight growth with shaking at 30C. Individual diploid cultures were screened by fluorescence microscopy for
presence of Rnq1‐GFP aggregates versus diffuse fluorescence, indicative of [PIN +] loss. Cell populations of
individual colonies were scored by the following: all cells had Rnq1‐GFP aggregates ([PIN +]), only a
subpopulation of cells had aggregates (partial), or all cells showed diffuse Rnq1‐GFP fluorescence ([pin −]).
To generate colonies representing 60 generations from cryogenic storage, but also to avoid founder effects, cells
from the densely populated region of the above “40‐generation” YPD plate were further subcloned by streaking
on a fresh YPD plate to generate ~100 “60‐generation” single colonies. Precisely as described above, “60‐
generation” single colonies were picked to 96‐well plates, pinned to YPD, mated to the D163 tester containing
p3036, grown on SD‐Leu‐Ura plates, pinned to SD‐Leu‐Ura liquid media with 25 µM CuSO4 for overnight growth
at 30°C, and screened for the number of colonies that were [PIN +]. This entire procedure from densely
populated region of cell harvest up through microscopic screening was repeated for 80 and 100 generations.
To test mitotic stability in the presence of low‐level Rnq1‐GFP expression, strains representing cells f, g, and h,
and retaining the RNQ1‐GFP plasmid (HIS3, p3034) used for plasmiduction, were streaked from cryogenic
storage onto SD‐His plates. Stability experiments were carried out similar to above, except that strains were
successively subcloned onto SD‐His plates that did not include any supplemented CuSO4, such that the only
Rnq1‐GFP expression was generated through the trace copper found in the media. Single colonies, along with
desired [PIN +] and [pin −] controls, were then picked directly into 96‐well plates containing SD‐His liquid with
25 µM CuSO4, and grown at 30°C overnight with shaking. Individual cultures were screened by fluorescence
microscopy for presence of Rnq1‐GFP aggregates versus diffuse fluorescence indicative of [PIN +] loss.
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